Lung cancer · In the news · Oct 2026
He flew to Shanghai
for his mother’s cancer pill.
Max Doppelt’s mother has a rare lung cancer that spread to her brain. The drug most likely to help, sunvozertinib, had been sold in China since 2023 but not in the US. Here is the story in English, where the drug stands now, and what to check before you travel for cancer care.
Transcript
What the clip says, in English.
The clip has music only. This is our translation of Yangtse Evening Post’s Chinese subtitles. One line needs an update: the drug did receive FDA approval in July 2025, but it was still not on sale in the US when the story ran.
- 0:00
On October 22, a post by an American man, Max, about getting a drug from abroad sparked debate online.
10月22日,美国男子马克斯的一篇“跨国求药”的帖子在社交媒体上引发热议
- 0:04
He said his mother was diagnosed with lung cancer three years ago. Despite chemotherapy, immunotherapy and surgery, in December 2024 it spread to her brain, and no effective treatment could be found in the US.
他表示,他的母亲3年前确诊肺癌,虽经化疗、免疫治疗和手术治疗,但到2024年12月还是转移到脑部。令人绝望的是,在美国找不到有效的治疗办法
- 0:08
A doctor told him about a Chinese targeted drug, sunvozertinib, that could not be bought in the US, so he set off for China to buy it. Nineteen months on, his mother's cancer is largely under control.
医生表示,中国研发出一种靶向药“舒沃替尼”,但在美国无法买到,于是他立即启程前往中国买药。令人兴奋的是,用药19个月后,母亲的病情已被基本控制住
- 0:12
His story drew wide discussion. Max says he knows of at least 30 Americans who have made the same trip.
这段亲身经历在网络引起大量讨论。马克斯表示,据他所知已有至少30名美国人像他一样在“跨国求药”
What happened
From New York to Shanghai,
26 boxes at a time.
- Late 2023
A cough turns out to be lung cancer
Debbie Doppelt, 60, who runs a jewellery business in New York with her husband, was diagnosed with an uncommon lung cancer that mostly affects non-smokers. Shanghai Daily reports it is driven by an EGFR exon 20 insertion. Chemotherapy, immunotherapy and surgery held it back for months.
Source: KFF Health News; Shanghai Daily
- Dec 2024 – Jan 2025
It spreads to her brain
Scans showed about ten tiny brain tumours (December 2024 in KFF Health News; The Star says January 2025). She was ruled ineligible for a US trial of another drug because of slight lung scarring. A doctor remarked that if she lived in China she could simply buy sunvozertinib there, where it had been approved since 2023.
Source: KFF Health News; The Star
- 2025
First pills, then a trip to Shanghai
The family first got a small supply through a contact living in China. A few months later Max flew to Shanghai and came home with 26 boxes, which he says cost about US$10,000. The reports do not say which pharmacy or doctor was involved.
Source: KFF Health News; Shanghai Daily
- Jul 2025
FDA accelerated approval
The FDA granted accelerated approval to sunvozertinib (brand name Zegfrovy) for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations that has progressed on or after platinum chemotherapy. Approval did not mean US pharmacies could supply it, and as of October 2026 it was still not on the US market.
Source: Dizal; KFF Health News
- Oct 2026
19 months on, the post goes viral
Some 19 months after starting the drug, her cancer was still mostly held back, with a few radiation treatments and dose adjustments along the way. Max says he knows of at least 30 Americans who have made the same trip. AstraZeneca, which licensed the drug from Dizal, plans US availability by early 2027.
Source: KFF Health News; The Star; Yangtse Evening Post
Before you go
A hopeful story,
with real limits.
| Question | Why it matters |
|---|---|
| Does your tumour have the right mutation? | Sunvozertinib targets EGFR exon 20 insertions only. You need a genetic (NGS) test report that shows it. |
| Is it available at home yet? | Approval and availability are different things. Check with your oncologist, the manufacturer and any expanded-access programme first. |
| Who supervises treatment? | Targeted drugs need monitoring, scans and dose changes. Debbie’s care included radiation and dose adjustments. Your home oncologist should stay involved. |
| Can you bring it home? | The FDA may allow a limited personal supply in some cases; it is at the agency’s discretion. Read the FDA personal importation page before you travel. |
| Is it genuine? | Buy only through a hospital or licensed pharmacy with a prescription from a doctor licensed in China, and keep the receipts and packaging. |
It does not work for everyone. Max says it seems to help about half of those who take it, and another patient he helped found it stopped working after three months. See our lung cancer in China and clinical trials in China guides. Educational only, not medical advice.
How we can help
An oncology visit in China,
done properly.
We arrange in-person consultations with thoracic oncology teams at major Chinese cancer hospitals, translate your records and genetic reports beforehand, and send a medical interpreter with you. If a doctor there decides a drug approved in China suits you, the prescription and dispensing happen through the hospital. We do not buy, sell or ship medicines.
A trip can also include a second opinion on your treatment plan and a check of Chinese trials you may qualify for. Start with a records review so you know whether the trip is worth making.
FAQ
Sunvozertinib and China, answered.
- What is sunvozertinib?
- Sunvozertinib is a once-daily targeted pill from Dizal Pharmaceutical in Shanghai for non-small cell lung cancer with EGFR exon 20 insertion mutations, an uncommon subtype that responds poorly to older EGFR drugs. It was approved in China in 2023 and received FDA accelerated approval in July 2025 under the brand name Zegfrovy.
- Can I buy sunvozertinib in the US now?
- As of October 2026 it was not yet sold in the US, despite the 2025 approval. AstraZeneca licensed the drug and said it plans US availability by early 2027. Ask your oncologist about expanded access or trials in the meantime; the situation may have changed since this page was written.
- Does it work for everyone?
- No. Max himself says it seems to help about half the people who take it, and KFF Health News reports another woman he helped found it stopped working after three months. Debbie's 19 months of control also involved radiation and dose changes. It only applies to tumours with an EGFR exon 20 insertion, which needs a genetic test to confirm.
- Is it legal to bring cancer medicine back from China?
- It depends, and the decision belongs to US Customs and the FDA at the border. Under the FDA's personal importation policy, the agency may allow a patient to bring in a limited supply, generally up to three months, of an unapproved drug for a serious condition when no effective US treatment is available and a US doctor is supervising care. That is discretion, not a right. Check the FDA's personal importation page and talk to your doctor before you travel.
- Do I need a prescription to buy it in China?
- Yes. Sunvozertinib is a prescription drug in China, so you need a prescription from a doctor licensed there. In practice that means an in-person oncology consultation, bringing your scans, pathology and genetic test report. We can arrange that consultation; we do not buy, sell or ship medicines.
- What else can a China trip offer a lung cancer patient?
- Many targeted drugs and clinical trials reach China before other markets. A trip can combine a second opinion from a thoracic oncology team at a major cancer hospital, a review of trials you may be eligible for, and imaging if needed. Your home oncologist should stay in charge of your ongoing treatment.
Sources
Where this comes from.
- KFF Health News (Arthur Allen), “As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There”, 20 Oct 2026. Read it
- The Star, from South China Morning Post reporting, “'Saved my mum's life': Chinese cancer drug on sale in US after Americans travel to buy it”, 24 Oct 2026. Read it
- Shanghai Daily (Guo Jiayi), “26 Boxes of Hope: An American Son's Cancer-Drug Mission to Shanghai”, 1 Nov 2026. Read it
- Dizal Pharmaceutical (press release via BioSpace), “ZEGFROVY (sunvozertinib) receives FDA accelerated approval for NSCLC with EGFR exon 20 insertion mutations”, 3 Jul 2025. Read it
- US Food and Drug Administration, “Personal Importation”, FDA guidance page. Read it
Video: Yangtse Evening Post (扬子晚报); source Song Shifeng, editor Dai Zhehan. Music only; English captions translated by PandaTouring from the on-screen Chinese subtitles.
Related guides
Lung Cancer in China
Targeted therapy, surgery and leading thoracic oncology centres.
Read the guideClinical Trials in China
How foreign patients find and qualify for Chinese trials.
Read the guideCancer Treatment in China
What international patients can access, and how to plan it.
Read the guideSecond Opinion
A Chinese specialist review of your diagnosis and plan.
Read the guideWondering if a China trip
could help?
Send us your diagnosis and genetic test report. We’ll tell you honestly whether an oncology visit in China is worth it, and arrange it if it is.